Tz. Thomas et al., EXPRESSION AND LOCALIZATION OF ACTIVIN SUBUNITS AND FOLLISTATINS IN TISSUES FROM MEN WITH HIGH-GRADE PROSTATE-CANCER, The Journal of clinical endocrinology and metabolism, 82(11), 1997, pp. 3851-3858
Activins are growth and differentiation factors that have growth inhib
itory effects on LNCaP and DU145, but not PC3, human prostate tumor ce
ll lines. Activin-binding proteins, follistatins, block the inhibitory
actions of exogenously added activins on LNCaP and DU145 tumor cell L
ines. Based on these in vitro observations using human prostate tumor
cell lines, the aims of this study were to determine whether activins
and follistatins are expressed in the human prostate in tissues from m
en with high grade prostate cancer. The expression and cellular locali
zation of these proteins in malignant and nonmalignant regions of thes
e tissues were compared to determine whether any changes occur with pr
ogression to malignancy. The results demonstrate that activins and fol
listatins are synthesized in tissues from men with high grade prostate
cancer, and that messenger ribonucleic acid (mRNA) and protein for th
e activin beta A- and beta(B)-subunits and follistatin is expressed an
d localized to poorly differentiated tumor cells. In the nonmalignant
regions, activin beta(A) and beta(B) subunit mRNA and proteins are pre
dominantly localized to the epithelium. Follistatin mRNA was expressed
in the basal epithelial cells and in the fibroblastic stroma; however
, the localization of follistatin proteins using two specific antisera
demonstrated a difference between the follistatin isoforms expressed
in basal cells and the stroma. In the progression to malignancy, the c
olocalization of follistatin and activins to the tumor cells in vivo i
mplies that resistance to the growth inhibitory effects of activin may
be conferred by follistatins.